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A new method to bridge the gap between ligand and
receptor-based methods in virtual screening (VS) is pre-
sented. We introduce a structure-derived virtual ligand
(VL) model as an extension to a previously published
pseudo-ligand technique [1]: LIQUID [2] fuzzy pharma-
cophore virtual screening is combined with grid-based
protein binding site predictions of PocketPicker [3]. This
approach might help reduce bias introduced by manual
selection of binding site residues and introduces pocket
shape information to the VL. It allows for a combination
of several protein structure models into a single "fuzzy"
VL representation, which can be used to scan screening
compound collections for ligand structures with a similar
potential pharmacophore. PocketPicker employs an elab-
orate grid-based scanning procedure to determine buried
cavities and depressions on the protein's surface. Potential
binding sites are represented by clusters of grid probes
characterizing the shape and accessibility of a cavity. A
rule-based system is then applied to project reverse phar-
macophore types onto the grid probes of a selected
pocket. The pocket pharmacophore types are assigned
depending on the properties and geometry of the protein
residues surrounding the pocket with regard to their rela-
tive position towards the grid probes. LIQUID is used to
cluster representative pocket probes by their pharmacoph-
ore types describing a fuzzy VL model. The VL is encoded
in a correlation vector, which can then be compared to a
database of pre-calculated ligand models. A retrospective
screening using the fuzzy VL and several protein structures
was evaluated by ten fold cross-validation with ROC-AUC
and BEDROC metrics, obtaining a significant enrichment
of actives. Future work will be devoted to prospective
screening using a novel protein target of Helicobacter
pylori and compounds from commercial providers.
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